Nakamura K |
[Treatment of atopic dermatitis]. |
2009 |
Arerugi |
pmid:19901507
|
Saeki H |
[Brief commentary on guidelines for the management of atopic dermatitis 2012 -the point of drug treatment]. |
2013 |
Arerugi |
pmid:24608647
|
Ochiai T |
[Advances in the fundamentals and therapeutic use of immunosuppressive agents]. |
1992 |
Arerugi |
pmid:1374229
|
Ebihara N |
[New strategy in the treatment of vernal keratoconjunctivitis by calcineurin inhibitor eye drops]. |
2010 |
Arerugi |
pmid:21119297
|
Akutsu I et al. |
[Inhibitory effects of cyclosporin A and FK-506 on eosinophil chemotactic factor activity in culture supernatants of mononuclear cells from asthmatics]. |
1992 |
Arerugi |
pmid:1280086
|
Yamamoto S |
[Guidelines for the management of atopic dermatitis 2006]. |
2008 |
Arerugi |
pmid:19052504
|
Akutsu I et al. |
[Inhibitory effect of inhaled FK-506 on increased bronchial responsiveness and eosinophil infiltration in the airway mucosa]. |
1992 |
Arerugi |
pmid:1377905
|
Hossain M et al. |
Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability. |
1994 |
Arerugi |
pmid:7520689
|
Takehara K |
[Treatment of juvenile atopic dermatitis]. |
2010 |
Arerugi |
pmid:21212728
|
Akutsu I et al. |
[Inhibitory effect of FK-506 on the development of late asthmatic response and on the increased bronchial responsiveness]. |
1990 |
Arerugi |
pmid:1705791
|
Nishimoto K et al. |
[Case of organizing pneumonia associated with sweet's syndrome]. |
2014 |
Arerugi |
pmid:25163580
|
Müller EG et al. |
Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial. |
2017 |
Arq Bras Oftalmol |
pmid:28832739
|
Liendo VL et al. |
Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children. |
|
Arq Bras Oftalmol |
pmid:28954018
|
Zulim LFDC et al. |
Comparison of the efficacy of 0.03% tacrolimus eye drops diluted in olive oil and linseed oil for the treatment of keratoconjunctivitis sicca in dogs. |
|
Arq Bras Oftalmol |
pmid:29995121
|
Carvalho CS et al. |
[Fibroblasts from recurrent pterygium and normal Tenon's capsule exposed to tacrolimus (FK-506)]. |
2007 Mar-Apr |
Arq Bras Oftalmol |
pmid:17589693
|
Lasa J and Olivera P |
EFFICACY OF TACROLIMUS FOR INDUCTION OF REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. |
|
Arq Gastroenterol |
pmid:28327826
|
Long C et al. |
Removal of FKBP12/12.6 from endothelial ryanodine receptors leads to an intracellular calcium leak and endothelial dysfunction. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17478757
|
Ikezoe T et al. |
Thrombomodulin protects endothelial cells from a calcineurin inhibitor-induced cytotoxicity by upregulation of extracellular signal-regulated kinase/myeloid leukemia cell-1 signaling. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:22796578
|
Murakami R et al. |
Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells. |
2003 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12958044
|
Vindis C et al. |
Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15618541
|
Migita K et al. |
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus. |
2015 |
Arthritis Res. Ther. |
pmid:26036592
|
Choe JY et al. |
Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes. |
2013 |
Arthritis Res. Ther. |
pmid:23406906
|
van der Windt AE et al. |
Inhibiting calcineurin activity under physiologic tonicity elevates anabolic but suppresses catabolic chondrocyte markers. |
2012 |
Arthritis Rheum. |
pmid:22231955
|
Suzuki N et al. |
In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's disease. |
1997 |
Arthritis Rheum. |
pmid:9182928
|
de Paulis A et al. |
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. |
1997 |
Arthritis Rheum. |
pmid:9082935
|
Cho ML et al. |
Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes. |
2002 |
Arthritis Rheum. |
pmid:11817607
|
Kremer JM et al. |
Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study. |
2003 |
Arthritis Rheum. |
pmid:14558080
|
Asano Y et al. |
Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts. |
2005 |
Arthritis Rheum. |
pmid:15818662
|
Wilkes MR et al. |
Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. |
2005 |
Arthritis Rheum. |
pmid:16052580
|
Stone JH et al. |
Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls. |
1998 |
Arthritis Rheum. |
pmid:9704643
|
Yocum DE et al. |
Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial. |
2003 |
Arthritis Rheum. |
pmid:14673984
|
Furst DE et al. |
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. |
2002 |
Arthritis Rheum. |
pmid:12209503
|
Cho ML et al. |
Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. |
2002 |
Arthritis Rheum. |
pmid:12115224
|
Parker CT and Rennie T |
Failure to report previously used drugs and dosages in pharmaceutical company-sponsored rheumatoid arthritis trials: comment on the article by Yocum et al. |
2004 |
Arthritis Rheum. |
pmid:15457479
|
Haisheng H et al. |
Assessment of nerve regeneration across nerve allografts treated with tacrolimus. |
2008 |
Artif Cells Blood Substit Immobil Biotechnol |
pmid:18925465
|
Dawson S et al. |
UCLA liver transplantation: analysis of immunological factors affecting outcome. |
1996 |
Artif Organs |
pmid:8896726
|
Kashu Y et al. |
Prolongation of rat liver graft survival by splenectomy combined with low dose FK506 therapy. |
1996 |
Artif Organs |
pmid:8896731
|
Ohshima S et al. |
Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors. |
1996 |
Artif Organs |
pmid:8896734
|
Wada Y et al. |
BCX-34: a novel T-cell selective immunosuppressant: purine nucleoside phosphorylase (PNP) inhibitor. |
1996 |
Artif Organs |
pmid:8853794
|
Imanishi Y et al. |
Pharmacokinetic properties of a once-daily formulation of tacrolimus in patients with renal transplantation. |
2011 |
Arzneimittelforschung |
pmid:21528645
|
Takayama T et al. |
Effects of the novel and potent lymphocyte-specific protein tyrosine kinase inhibitor TKM0150 on mixed lymphocyte reaction and contact hypersensitivity in mice. |
2010 |
Arzneimittelforschung |
pmid:20533766
|
Lainesse A et al. |
Bioequivalence studies of tacrolimus capsule under fasting and fed conditions in healthy male and female subjects. |
2008 |
Arzneimittelforschung |
pmid:18589558
|
Haehner T et al. |
Drug-drug interactions evaluated by a highly active reconstituted native human cytochrome P4503A4 and human NADPH-cytochrome P450 reductase system. |
2004 |
Arzneimittelforschung |
pmid:14979613
|
MarcelÃn-Jiménez G et al. |
Development of an ultra-performance liquid chromatography technique coupled with mass spectrometry for the measurement of tacrolimus in micro-samples of whole blood, and its application on a pharmacokiinetic trial. |
2007 |
Arzneimittelforschung |
pmid:18074760
|
Iwasaki K et al. |
Effect of repeated oral doses of a novel immunosuppressive macrolide lactone on hepatic mixed-function oxidase system in the rat. Comparative study with ciclosporin. |
1992 |
Arzneimittelforschung |
pmid:1379812
|
Cacciarelli TV et al. |
Influence of the timing of FK 506 (Tacrolimus) administration on recovery of renal function from warm ischemic injury in rats. |
1994 Oct-Dec |
ASAIO J. |
pmid:7532042
|
Tsubo T et al. |
Elimination of FK-506 by continuous hemodiafiltration in a liver transplant patient. |
1997 Jul-Aug |
ASAIO J. |
pmid:9242954
|
Ogita K et al. |
Renal tubular acidosis secondary to FK506 in living donor liver transplantation: a case report. |
2003 |
Asian J Surg |
pmid:14530108
|
Li T et al. |
Effect of FK506 nanospheres on regeneration of allogeneic nerve after transplant. |
2014 |
Asian Pac J Trop Med |
pmid:25066398
|
Dai YJ et al. |
Effect of pharmacological intervention on MIP-1α, MIP-1β and MCP-1 expression in patients with psoriasis vulgaris. |
2014 |
Asian Pac J Trop Med |
pmid:25063291
|
Yasukochi Y et al. |
Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments. |
2014 |
Asian Pac. J. Allergy Immunol. |
pmid:25268342
|
Labcharoenwongs P et al. |
A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children. |
2012 |
Asian Pac. J. Allergy Immunol. |
pmid:23156846
|
Manuyakorn W et al. |
In vitro cytokine changes after pediatric liver transplantation. |
2015 |
Asian Pac. J. Allergy Immunol. |
pmid:25840634
|
Clark K et al. |
Oxidative Stress Induces Disruption of the Axon Initial Segment. |
|
ASN Neuro |
pmid:29228786
|
Riba Torrecillas D et al. |
[Use of topical tacrolimus and its side-effects]. |
2005 |
Aten Primaria |
pmid:15946616
|
Ichimaru N et al. |
Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. |
2001 |
Atherosclerosis |
pmid:11583721
|
Hamada N et al. |
Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model. |
2010 |
Atherosclerosis |
pmid:19682688
|
Matsumoto T et al. |
Influence of FK506 on experimental atherosclerosis in cholesterol-fed rabbits. |
1998 |
Atherosclerosis |
pmid:9699896
|
Grillo E et al. |
Necrobiosis lipoidica. |
2014 |
Aust Fam Physician |
pmid:24600675
|
Grillo E et al. |
Skin rash associated with limb weakness. |
2012 |
Aust Fam Physician |
pmid:23210105
|
Cooley HM et al. |
Resolution of pyoderma gangrenosum using tacolimus (FK-506) |
1996 |
Aust N Z J Med |
pmid:8744629
|
Chung TH et al. |
Topical tacrolimus (FK506) for the treatment of feline idiopathic facial dermatitis. |
2009 |
Aust. Vet. J. |
pmid:19796164
|
Dall'Olio E et al. |
Erosive pustular dermatosis of the leg: long-term control with topical tacrolimus. |
2011 |
Australas. J. Dermatol. |
pmid:21332681
|
Shamsudin N et al. |
Objective assessment of vitiligo with a computerised digital imaging analysis system. |
2015 |
Australas. J. Dermatol. |
pmid:25367709
|
Dar NR and Rao SU |
Facial lichen nitidus actinicus. |
2012 |
Australas. J. Dermatol. |
pmid:22571575
|
Milcic D and Nikolic M |
Clinical effects of topical pimecrolimus in a patient with Fox-Fordyce disease. |
2012 |
Australas. J. Dermatol. |
pmid:22571582
|
Lee FJ et al. |
Poor efficacy of oral tacrolimus in the treatment of severe generalized atopic eczema in adults: a small retrospective case series. |
2012 |
Australas. J. Dermatol. |
pmid:23157781
|
Zirbs M et al. |
Demodicidosis associated with psoriasis therapy--two case reports. |
2013 |
Australas. J. Dermatol. |
pmid:23905976
|
Patterson C and Coutts I |
Granuloma faciale successfully treated with topical tacrolimus. |
2009 |
Australas. J. Dermatol. |
pmid:19659988
|
Cassis TB and Callen JP |
Bupropion-induced subacute cutaneous lupus erythematosus. |
2005 |
Australas. J. Dermatol. |
pmid:16197429
|
Wilson LM and Reid CM |
Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment. |
2004 |
Australas. J. Dermatol. |
pmid:15250900
|
Christophers E |
Psoriasis: mechanisms and entry points for possible therapeutic interventions. |
1996 |
Australas. J. Dermatol. |
pmid:8713012
|
Pirmez R et al. |
Acne keloidalis nuchae in renal transplant patients receiving tacrolimus and sirolimus. |
2016 |
Australas. J. Dermatol. |
pmid:27124649
|
Starritt E and Lee S |
Erythroplasia of Queyrat of the glans penis on a background of Zoon's plasma cell balanitis. |
2008 |
Australas. J. Dermatol. |
pmid:18412812
|
Black M and Marshman G |
Dermatomyositis and pemphigus vulgaris: association or coincidence? |
2011 |
Australas. J. Dermatol. |
pmid:21605086
|
Hannah J et al. |
Tacrolimus use in lupus nephritis: A systematic review and meta-analysis. |
2016 |
Autoimmun Rev |
pmid:26427983
|
Shinkura N et al. |
Autoantibodies to FK506 binding protein 12 (FKBP12) in autoimmune diseases. |
1999 |
Autoimmunity |
pmid:10433096
|
Maalej A et al. |
Evidence of association between FKBP1B and thyroid autoimmune disorders in a large Tunisian family. |
2004 |
Autoimmunity |
pmid:15497458
|
Thomson AW et al. |
ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. |
1993 |
Autoimmunity |
pmid:7505632
|
Lemster B et al. |
Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. |
1994 |
Autoimmunity |
pmid:7539635
|
Thomson AW and Starzl TE |
FK 506 and autoimmune disease: perspective and prospects. |
1992 |
Autoimmunity |
pmid:1382646
|
Mochizuki M and Kawashima H |
Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat. |
1990 |
Autoimmunity |
pmid:1717007
|
Ni M et al. |
FR900506 (FK506) and 15-deoxyspergualin (15-DSG) modulate the kinetics of infiltrating cells in eyes with experimental autoimmune uveoretinitis. |
1990 |
Autoimmunity |
pmid:1717008
|
Matsumura C et al. |
Differential effects of FK506 and cyclosporin A on catecholamine release from bovine adrenal chromaffin cells. |
2004 |
Auton Autacoid Pharmacol |
pmid:15541012
|
Nakagaki T et al. |
FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice. |
2013 |
Autophagy |
pmid:23800841
|
Gates T |
Atopic dermatitis: diagnosis, treatment, and aeromedical implications. |
2007 |
Aviat Space Environ Med |
pmid:17225479
|
Ekici Günay N et al. |
Administration of Extract (EGb761) Alone and in Combination with FK506 Promotes Liver Regeneration in a Rat Model of Partial Hepatectomy. |
2018 |
Balkan Med J |
pmid:29553465
|
Kise H et al. |
Cardiac and haemodynamic effects of tacrolimus in the halothane-anaesthetized dog. |
2010 |
Basic Clin. Pharmacol. Toxicol. |
pmid:19912168
|
Zhang H et al. |
Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling. |
2018 |
Basic Clin. Pharmacol. Toxicol. |
pmid:28945011
|
Han N et al. |
Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation. |
2014 |
Basic Clin. Pharmacol. Toxicol. |
pmid:24238261
|
Huang F et al. |
Pharmacokinetic Interaction between Faldaprevir and Cyclosporine or Tacrolimus in Healthy Volunteers: A Prospective, Open-Label, Fixed-Sequence, Crossover Study. |
2018 |
Basic Clin. Pharmacol. Toxicol. |
pmid:29427400
|
Quteineh L et al. |
Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients. |
2008 |
Basic Clin. Pharmacol. Toxicol. |
pmid:19067682
|
Kagaya H et al. |
Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation. |
2010 |
Basic Clin. Pharmacol. Toxicol. |
pmid:20136638
|
Kim IW et al. |
Identification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients. |
2012 |
Basic Clin. Pharmacol. Toxicol. |
pmid:22469198
|
Panahi Y et al. |
Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study. |
2009 |
Basic Clin. Pharmacol. Toxicol. |
pmid:19143752
|
Velickovic-Radovanovic RM et al. |
Clinical pharmacokinetics of tacrolimus after the first oral administration in renal transplant recipients on triple immunosuppressive therapy. |
2010 |
Basic Clin. Pharmacol. Toxicol. |
pmid:20102364
|
Hisamura F et al. |
Protective effect of green tea extract and tea polyphenols against FK506-induced cytotoxicity in renal cells. |
2006 |
Basic Clin. Pharmacol. Toxicol. |
pmid:16445594
|
Hu R et al. |
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation. |
2018 |
Basic Clin. Pharmacol. Toxicol. |
pmid:29603629
|
Cumming DV et al. |
Pharmacological preconditioning of primary rat cardiac myocytes by FK506. |
1996 Sep-Oct |
Basic Res. Cardiol. |
pmid:8922254
|
Ikeda Y et al. |
Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by delta-opioid receptor activation. |
2006 |
Basic Res. Cardiol. |
pmid:16619106
|